NDC 0409-1810 - Novocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1810
- Package NDCs from labels
- 0409-1810-02
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-08-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-08-28 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1810-02 | Novocaine | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 2 | |
| 0409-1810-02 | Novocaine | 5 in 1 CONTAINER | INJECTION, SOLUTION | 5 | 2 | |
| 0409-1810-02 | Novocaine | 40 in 1 CASE | INJECTION, SOLUTION | 40 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Hospira, Inc. | 67908e20-044d-454d-9c51-bf106e817bd0 | 2026-05-25 | Warnings, Adverse reactions | Hospira, Inc. |
| Heparin Sodium and Dextrose | HEPARIN SODIUM | Hospira, Inc. | eede8a0c-5ae6-4166-84b3-12081405f08e | 2026-05-25 | Warnings, Adverse reactions | Hospira, Inc. |
| Diltiazem Hydrochloride | DILTIAZEM HYDROCHLORIDE | Hospira, Inc. | bba03666-ff4f-4bf6-fa92-78e1ec2d9073 | 2026-05-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Ondansetron | ONDANSETRON | Hospira, Inc. | d62cd60b-f87e-4825-bead-1d18bbc4e480 | 2026-05-23 | Warnings, Adverse reactions | Hospira, Inc. |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 89a4bd73-89f4-4fd7-2c9f-921e1da8f96b | 2026-05-22 | Warnings, Adverse reactions | Hospira, Inc. |
| Diazepam | DIAZEPAM | Hospira, Inc. | 7e7dd743-a87b-4ab3-b6ae-f116cd0c8b0f | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Acetylcysteine | ACETYLCYSTEINE | Hospira, Inc. | 5558a5f5-e821-473b-7d8a-5d33d09f0586 | 2026-05-22 | Warnings, Adverse reactions | Hospira, Inc. |
| LMD in Dextrose | DEXTRAN 40 | Hospira, Inc. | 3c273512-84e2-2cea-b201-12345a6bd1fe | 2026-05-22 | Warnings, Adverse reactions | Hospira, Inc. |
| Aminophylline | AMINOPHYLLINE | Hospira, Inc. | 9a663ef3-881f-48bd-2689-3713b24545c2 | 2026-05-22 | Warnings, Adverse reactions | Hospira, Inc. |
| Ondansetron | ONDANSETRON | Hospira, Inc. | 6a11f61b-2318-4382-2b91-4366e4bb53fa | 2026-05-22 | Warnings, Adverse reactions | Hospira, Inc. |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Hospira, Inc. | 87d6e9dc-fe3b-4593-ac9a-d7493d1959c7 | 2026-05-22 | Warnings, Adverse reactions | Hospira, Inc. |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Hospira, Inc. | 7c1f998a-233d-4feb-6ea2-457702abd0d2 | 2026-05-21 | Warnings, Adverse reactions | Hospira, Inc. |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Hospira, Inc. | 977180b3-a222-4282-d485-4a3217674305 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Precedex | DEXMEDETOMIDINE HYDROCHLORIDE | Hospira, Inc. | 548a88c0-afda-427e-75ac-5af0cfa2224c | 2026-05-20 | Warnings, Adverse reactions | Hospira, Inc. |
| Amidate | ETOMIDATE | Hospira, Inc. | b7ed5bf8-ba75-44dc-8f81-96b4ad5766be | 2026-05-20 | Warnings, Adverse reactions | Hospira, Inc. |
| Hextend | HETASTARCH | Hospira, Inc. | fc79700c-6c3b-4998-8307-4dc8c81c5041 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Metoclopramide | METOCLOPRAMIDE | Hospira, Inc. | 146803a1-199d-4789-b128-e974bdd03322 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | Hospira, Inc. | a2a964f7-c3ec-4dfb-e3a0-6d8136a80397 | 2026-05-19 | Warnings, Adverse reactions | Hospira, Inc. |
| Atropine Sulfate | ATROPINE SULFATE | Hospira, Inc. | ad8916e7-206e-409e-2582-30d072845dd4 | 2026-05-18 | Warnings, Adverse reactions | Hospira, Inc. |
| COPPER | CUPRIC CHLORIDE | Hospira, Inc. | a84d61a4-8e7f-4be1-aba6-f633b334aafc | 2026-05-18 | Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.